Literature DB >> 19765557

The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

E J Van Bockstaele1, B A S Reyes, R J Valentino.   

Abstract

The interaction between the stress axis and endogenous opioid systems has gained substantial clinical attention as it is increasingly recognized that stress predisposes to opiate abuse. For example, stress has been implicated as a risk factor in vulnerability to the initiation and maintenance of opiate abuse and is thought to play an important role in relapse in subjects with a history of abuse. Numerous reports indicating that stress alters individual sensitivity to opiates suggest that prior stress can influence the pharmacodynamics of opiates that are used in clinical settings. Conversely, the effects of opiates on different components of the stress axis can impact on individual responsivity to stressors and potentially predispose individuals to stress-related psychiatric disorders. One site at which opiates and stress substrates may interact to have global effects on behavior is within the locus coeruleus (LC), the major brain norepinephrine (NE)-containing nucleus. This review summarizes our current knowledge regarding the anatomical and neurochemical afferent regulation of the LC. It then presents physiological studies demonstrating opposing interactions between opioids and stress-related neuropeptides in the LC and summarizes results showing that chronic morphine exposure sensitizes the LC-NE system to corticotropin releasing factor and stress. Finally, new evidence for novel presynaptic actions of kappa-opioids on LC afferents is provided that adds another dimension to our model of how this central NE system is co-regulated by opioids and stress-related peptides. Copyright 2009. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765557      PMCID: PMC3274960          DOI: 10.1016/j.brainres.2009.09.036

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  159 in total

1.  Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.

Authors:  A L Curtis; S M Lechner; L A Pavcovich; R J Valentino
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

2.  Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles.

Authors:  A L Svingos; C Chavkin; E E Colago; V M Pickel
Journal:  Synapse       Date:  2001-12-01       Impact factor: 2.562

3.  Evidence for coexistence of enkephalin and glutamate in axon terminals and cellular sites for functional interactions of their receptors in the rat locus coeruleus.

Authors:  E J Van Bockstaele; A Saunders; K G Commons; X B Liu; J Peoples
Journal:  J Comp Neurol       Date:  2000-01-31       Impact factor: 3.215

4.  Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions.

Authors:  M Ishimatsu; J T Williams
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

5.  Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

Authors:  A L Svingos; E E Colago; V M Pickel
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

6.  Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents.

Authors:  B A S Reyes; G Drolet; E J Van Bockstaele
Journal:  J Comp Neurol       Date:  2008-06-01       Impact factor: 3.215

Review 7.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

8.  Locus ceruleus discharge characteristics of morphine-dependent rats: effects of naltrexone.

Authors:  R J Valentino; R G Wehby
Journal:  Brain Res       Date:  1989-05-29       Impact factor: 3.252

9.  Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

Authors:  Tracie A Paine; Hilarie C Tomasiewicz; Kehong Zhang; William A Carlezon
Journal:  Biol Psychiatry       Date:  2007-03-07       Impact factor: 13.382

10.  Sensitization or tolerance to morphine effects after repeated stresses.

Authors:  G Benedek; M Szikszay
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

View more
  47 in total

1.  Delta opioid receptors colocalize with corticotropin releasing factor in hippocampal interneurons.

Authors:  T J Williams; T A Milner
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Differential Susceptibility of the Developing Brain to Contextual Adversity and Stress.

Authors:  W Thomas Boyce
Journal:  Neuropsychopharmacology       Date:  2015-09-22       Impact factor: 7.853

4.  Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.

Authors:  Emanuele Claudio Latagliata; Alessandro Valzania; Tiziana Pascucci; Paolo Campus; Simona Cabib; Stefano Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  2014-03-29       Impact factor: 4.530

5.  Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Authors:  Catherine S Hubbard; Jennifer S Labus; Joshua Bueller; Jean Stains; Brandall Suyenobu; George E Dukes; Dennis L Kelleher; Kirsten Tillisch; Bruce D Naliboff; Emeran A Mayer
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

Review 6.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

Review 7.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

8.  Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-04-06       Impact factor: 4.530

9.  Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.

Authors:  Meritxell Llorca-Torralba; Fuencisla Pilar-Cuéllar; Lidia Bravo; Cristina Bruzos-Cidon; María Torrecilla; Juan A Mico; Luisa Ugedo; Emilio Garro-Martínez; Esther Berrocoso
Journal:  Mol Neurobiol       Date:  2018-10-03       Impact factor: 5.590

10.  The Sensory Impact of Nicotine on Noradrenergic and Dopaminergic Neurons of the Nicotine Reward - Addiction Neurocircuitry.

Authors:  Jed E Rose; Ozra Dehkordi; Kebreten F Manaye; Richard M Millis; Salman Ameri Cianaki; Annapurni Jayam-Trouth
Journal:  J Addict Res Ther       Date:  2016-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.